Cellular Pharmacodynamics of Small Molecules in Lysosomal Storage Disorders

Status unconfirmed

Conditions studied: Lysosomal Storage Diseases

In brief

The purpose of this study is to evaluate the effect of small molecule therapy in primary cells derived from patients with lysosomal storage disease. The study will focus on activity of small molecules, in terms of measurements enzymes activity and level of substrates accumulations. Also, the effects of small molecules on cell function, including autophagy-lysosomal pathways, metabolism, mitochondrial function and immune reaction will be investigated.

Key facts

Study ID
NCT03812055
Run by
Lysosomal and Rare Disorders Research and Treatment Center, Inc.
People needed
50
Starts
2018-07-06
Expected to finish
2020-07-01
Last updated by the study team
2019-01-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.